SeqLL Awarded SBIR to Advance the Development of Direct RNA Sequencing (DRS™) Technology
July 11, 2017 08:36 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single Molecule Sequencing (tSMS™) platform. The... Read more